# OXYBUTYNIN
> **ANDA090526** · Abbreviated New Drug Application (Generic) · Sponsor: BARR LABS DIV TEVA · Approved 2014-03-04
## Drug
- **FDA Application Number:** ANDA090526
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXYBUTYNIN
- **Generic name:** Oxybutynin
- **Active ingredients:** OXYBUTYNIN
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Discontinued
- **Sponsor:** BARR LABS DIV TEVA
- **First approval:** 2014-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090526)
---
*AI Analytics · CC0 1.0*